Clinical and Biochemical Phenotype of Adolescent Males with Gynecomastia

被引:11
作者
Lorek, Milosz [1 ]
Tobolska-Lorek, Dominika [1 ]
Kalina-Faska, Barbara [1 ]
Januszek-Trzciakowska, Aleksandra [1 ]
Gawlik, Aneta [1 ]
机构
[1] Med Univ Silesia, Fac Med, Dept Pediat & Pediat Endocrinol, Katowice, Poland
关键词
Gynecomastia; puberty; estradiol; testosterone; ratio; PUBERTAL GYNECOMASTIA; CHILDREN; BOYS;
D O I
10.4274/jcrpe.galenos.2019.2019.0027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Gynecomastia is defined as a benign proliferation of male breast glandular tissue. Its prevalence during puberty varies between 50-60% and is also common in neonatal and elderly males. It develops mainly due to the disequilibrium between estrogen and androgen activity in breast tissue, where estradiol (E2) binds to estrogen receptors and stimulates ductal and glandular cells. The aim of this work was to investigate the relationship between sex hormone alterations and the natural history of gynecomastia. Methods: Participants in this study were young males referred to an outpatient clinic, between January 2011 and February 2016, with breast enlargement. Thyroid function, liver function, hormone concentrations and tumor markers were measured and anthropometric assessment was conducted. Results: Subjects comprised 93 males, aged 9 to 18 (mean +/- standard deviation age 13.8 +/- 2.6) years. In 63 of 93 (67.7%) the gynecomastia was confirmed and 28 were followed-up for a median period of three months. None of the boys showed any reduction in breast size during follow-up. There was no correlation between body mass index Z-score and breast size. Breast enlargement progressed in nine boys (32.1%). A positive correlation between estrogen to testosterone (E2/TTE) ratio and Tanner B stage (r = 0.47; p = 0.034) was observed. Conclusion: The E2/TTE ratio may be a helpful tool in diagnosing gynecomastia. Altered E2/TTE ratio might be responsible for a proportion of cases described previously as idiopathic. Additionally, weight loss does not imply reduction of breast size in boys. Nonetheless it should be the first step in the management of prolonged gynecomastia.
引用
收藏
页码:388 / 394
页数:7
相关论文
共 36 条
  • [1] Akgul S, 2017, INT J ADOLESC MED HL, V31, P446, DOI [10.1515/ijamh-2017-0011, DOI 10.1515/IJAMH-2017-0011]
  • [2] Hormonal, anthropometric and lipid factors associated with idiopathic pubertal gynecomastia
    Al Alwan, Ibrahim
    Al Azkawi, Hanan
    Badri, Motasim
    Tamim, Hani
    Al Dubayee, Mohammed
    Tamimi, Waleed
    [J]. ANNALS OF SAUDI MEDICINE, 2013, 33 (06) : 579 - 583
  • [3] Twenty-four hours secretion pattern of serum estradiol in healthy prepubertal and pubertal boys as determined by a validated ultra-sensitive extraction RIA
    Ankarberg-Lindgren C.
    Norjavaara E.
    [J]. BMC Endocrine Disorders, 8 (1)
  • [4] Gynecomastia: Its features, and when and how to treat it
    Bembo, SA
    Carlson, HE
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2004, 71 (06) : 511 - 517
  • [5] Gynecomastia among HIV-infected patients is associated with hypogonadism:: A case-control study
    Biglia, A
    Blanco, JL
    Martínez, E
    Domingo, P
    Casamitjana, R
    Sambeat, MA
    Milinkovic, A
    Garcia, M
    Laguno, M
    Leon, A
    Larrousse, M
    Lonca, M
    Mallolas, J
    Gatell, JM
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (10) : 1514 - 1519
  • [6] Drug-Induced Gynecomastia
    Bowman, John D.
    Kim, Hyunah
    Bustamante, Juan J.
    [J]. PHARMACOTHERAPY, 2012, 32 (12): : 1123 - 1140
  • [7] BRAUNSTEIN GD, 1993, NEW ENGL J MED, V328, P490
  • [8] Braunstein Glenn D, 2004, AIDS Read, V14, P38
  • [9] Approach to the Patient with Gynecomastia
    Carlson, Harold E.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (01) : 15 - 21
  • [10] Daniels IR, 2001, EUR J SURG, V167, P885